8 Results for "

senolytics

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "senolytics" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-P4157
CAS No.: 2460055-10-9
Target:  

MDM-2/p53 Apoptosis

Research Areas:  

Metabolic Disease

FOXO4-DRI is a cell-permeable peptide antagonist that blocks the interaction of FOXO4 and p53. FOXO4-DRI is a senolytic peptide that induces apoptosis of senescent cells .
loading...
    loading...
Cat. No.: HY-170851
Target:  

Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

GL392 is a senolytic agent that selectively delivers the potent senolytic compound Dasatinib (HY-10181) to senescent cells. GL392 targets lipofuscin in senescent cells via the LBD domain and is linked to Dasatinib through an ester bond. Upon internalization in senescent cells, Dasatinib is released, inducing apoptosis of the senescent cells. GL392 in micelle encapsulation (mGL392) enables selective delivery to senescent cells, achieving selective senescent cell elimination in vitro and in vivo. GL392 can be used for the research of melanoma .
loading...
    loading...
Cat. No.: HY-169265
CAS No.: 452350-43-5
Target:  

Bcl-2 Family

Research Areas:  

Others

BRD-K20733377 is an inhibitor for Bcl-2, and exhibits selective cytotoxicity against senescent cells, that inhibits the viability of Etoposide (HY-13629)-induced IMR-90 senescent cell with an IC50 of 10.7 μM. BRD-K20733377 reduces the mRNA expression of aging-related genes p16, p21 and KI67 in aged mouse model .
loading...
    loading...
Cat. No.: HY-176049
CAS No.: 3079237-53-6
Target:  

Drug Derivative

Research Areas:  

Neurological Disease

Dasatinib derivative 1 (2e) effectively releases NO and increases the concentration of 3′,5′-cyclic guanosine monophosphate, as well as maintains senolytic activity. Dasatinib derivative 1 (2e) can be used in the research for chronic ocular hypertension (COHT) glaucoma .
loading...
    loading...
Cat. No.: HY-P4157A
Target:  

MDM-2/p53 Apoptosis

Research Areas:  

Metabolic Disease

FOXO4-DRI acetate is a cell-permeable peptide antagonist that blocks the interaction of FOXO4 and p53. FOXO4-DRI acetate is a senolytic peptide that induces apoptosis of senescent cells .
loading...
    loading...
Cat. No.: HY-161088
CAS No.: 1884611-28-2
Target:  

Drug Derivative ERK

Research Areas:  

Others

Anti-aging agent 1 (compound 24) is a derivative of piperlongumine (HY-N2329) (PL). Anti-aging agent 1 exhibits a 50-fold enhancement in senolytic activity against senescent WI-38 fibroblasts compared to PL .
loading...
    loading...
Cat. No.: HY-173337
CAS No.: 184897-90-3
Target:  

HSP Interleukin Related

Research Areas:  

Cancer

HSP90α-IN-1 is a HSP90α inhibitor (IC50 = 111 nM) that exhibits senolytic activity across various cellular senescence models. HSP90α-IN-1 is related to the xanthinic family. HSP90α-IN-1 is involved in research on combating age-related inflammaging and diseases, including cancer, and possibly extend a healthy lifespan .
loading...
    loading...
Cat. No.: HY-183306
Target:  

mTOR STAT

mTOR/STAT3-IN-1 is a dual mTOR/STAT3 inhibitor. mTOR/STAT3-IN-1 exhibits potent mTOR inhibitory activity and moderate STAT3 inhibitory activity, while exerting cell type-dependent antiproliferative and senolytic activities in human cell lines. mTOR/STAT3-IN-1 can be used in the research of glioblastoma and aging-related diseases .
loading...
    loading...